- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT00560898
Comparison of Two Multi-Purpose Solution and Lens Material Combinations on Corneal Barrier Function
19 maj 2008 uppdaterad av: Southern California College of Optometry at Marshall B. Ketchum University
Comparison of Two Multi-Purpose Solution and Contact Lens Material Combinations on Human Corneal Barrier Function
The purpose of this study is to measure the relative "barrier" function of the top layer of the cornea (called the epithelium), or the degree to which the cornea can prevent the penetration of the colored dye sodium fluorescein into the eye.
This is a clinical investigation of the effect on corneal barrier function following wear of two contact lens materials and two contact lens care systems, approved for marketing in the US by the Food and Drug Administration.
These contact lenses will be worn for two hours, following soak in one of two marketed contact lens disinfecting solutions.
Approximately 25 young, adapted contact lens wearers will participate.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
- Läkemedel: ProClear Lens Material soaked in ReNu Multiplus Multipurpose Solution
- Läkemedel: Acuvue Advance Lens Material soaked in ReNu Multiplus Multipurpose Solution
- Läkemedel: Acuvue Advance Lens Material soaked in Optifree RepleniSH Multipurpose Solution
- Läkemedel: ProClear Lens Material soaked in Optifree RepleniSH Multipurpose Solution
Studietyp
Interventionell
Inskrivning (Förväntat)
25
Fas
- Fas 4
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
California
-
Fullerton, California, Förenta staterna, 92831
- Southern California College of Optometry
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år till 80 år (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Ja
Kön som är behöriga för studier
Allt
Beskrivning
Inclusion Criteria:
At least 18 years of age.
- Understand your rights as a research subject and give written informed consent by signing the Informed Consent Form, Subject Bill of Rights, and Patient Authorization for Use and Release of Health and Research Study Information (HIPAA form).
- Be likely to finish the entire study, understand the study instructions, and be willing to follow the instructions.
- Contact lens prescription between +4.00 D to -9.00 D (spherical equivalent).
- Best correctable visual acuity of at least 20/40 in each eye.
- Willing to de-adapt (do not wear) from habitual contact lenses for periods of three days prior to barrier function determination.
- Possess a functional spectacle prescription to allow adequate vision during the de-adaptation and barrier function determination periods.
- No known ocular or systemic allergies, which may interfere with contact lens wear.
- No known systemic disease, or need for medication that may interfere with contact lens wear (i.e. antihistamines, beta-blockers, steroids).
Exclusion Criteria:
Subjects demonstrating any medical condition that may affect the results of this study SHOULD NOT be enrolled. The following are specific conditions that exclude subjects from enrollment in this study.
- Eye (ocular) or systemic allergies that may interfere with contact lens wear.
- Less than one month successful, full time (defined as more than 8 hours per day, and more than 5 days per week) soft lens wear.
- Systemic disease or uses of medication, which may interfere with contact lens wear.
- Clinically significant corneal swelling (greater than grade 3 or 4 on a 0-4 scale), corneal blood vessel growth) (vascularization), corneal staining, bulbar redness, tarsal redness, or any other abnormality of the cornea that may cause unsafe contact lens wear.
- Any active ocular infection.
- Prior corneal refractive surgery (i.e., LASIK, PRK, etc).
- Have used medications within 24 hours of study entry or have an ongoing need to use ocular medication.
- Are taking part in any other study or have taken part in a study within the last 14 days
- Have a medical condition that your study eye doctor thinks may make it not appropriate for you to participate in this study.
- Are pregnant, or anticipate becoming pregnant during the course of this study.
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Crossover tilldelning
- Maskning: Dubbel
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: 2
contact lenses disinfected in multipurpose solution
|
Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours
|
|
Experimentell: 3
contact lenses disinfected in multipurpose solution
|
Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours
|
|
Experimentell: 4
contact lenses disinfected in multipurpose solution
|
Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours
|
|
Experimentell: 1
contact lenses disinfected in multipurpose solution
|
Contact lens soaked in multipuprpose solution for 8 hours, then worn for two hours
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Epithelial penetration rate of sodium fluoeescein, in nm/sec
Tidsram: Immediately post measurement
|
Immediately post measurement
|
Sekundära resultatmått
Resultatmått |
Tidsram |
|---|---|
|
Corneal staining
Tidsram: Immediately following barrier determination
|
Immediately following barrier determination
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Samarbetspartners
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 september 2007
Primärt slutförande (Faktisk)
1 december 2007
Avslutad studie (Faktisk)
1 mars 2008
Studieregistreringsdatum
Först inskickad
15 november 2007
Först inskickad som uppfyllde QC-kriterierna
19 november 2007
Första postat (Uppskatta)
20 november 2007
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
20 maj 2008
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
19 maj 2008
Senast verifierad
1 maj 2008
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 00001418
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .